Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452917 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,502
- Enrollment target
NCT03452917 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 1,502 participants.
The verdict
NCT03452917, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,502 participants
- Enrollment target
Study Summary
In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the field by paramedics. The primary outcome will be proportion of patients surviving to hospital admission.
Interventions
- DRUG Placebo
- DRUG sodium nitrite 45 mg
- DRUG sodium nitrite 60 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,502 participants |
| Start Date | 2018-02-08 |
| Est. Completion | 2020-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03452917
The ClinicalTrials.gov registry entry for NCT03452917 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,502 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03452917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03452917 about?
NCT03452917 is a clinical study titled "Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest". In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the fie...
What is the current status of trial NCT03452917?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,502 participants. The study started on 2018-02-08. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT03452917?
The interventions under investigation include: Placebo (DRUG), sodium nitrite 45 mg (DRUG), sodium nitrite 60 mg (DRUG).
Who is sponsoring clinical trial NCT03452917?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.